NASDAQ:AMPH | Free Cash Flow | Amphastar Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$47.84M$9.51M$38.33M597.09%
2025-12-31$32.86M$8.27M$24.59M100.66%
2025-03-31$35.08M$10.7M$24.38M96.42%
2024-12-31$29.02M$12.41M$16.61M43.76%
2024-03-31$55.29M$8.79M$46.5M107.69%
2023-12-31$23.86M$9.44M$14.42M39.88%
2023-03-31$40.38M$9.48M$30.91M118.72%
2022-12-31$15.23M$6.31M$8.92M26.29%
2022-03-31$50.77M$6.14M$44.63M184.00%
2021-12-31$40.44M$6.88M$33.56M169.85%
2021-03-31$22.83M$7.62M$15.21M301.67%
2020-12-31$16.89M$9.33M$7.56M
2020-03-31$1.48M$8.01M-$6.53M-165.33%
2019-12-31$5.65M$8.41M-$2.76M
2019-03-31-$3.61M$14.74M-$18.35M-2114.52%
2018-12-31$9.52M$9.58M-$65,000.00-3.48%
2018-03-31$8.36M$12.34M-$3.98M
2017-12-31$9.77M$10.12M-$353,000.00-44.85%
2017-03-31$22.4M$7.27M$15.13M1694.40%
2016-12-31$14.01M$5.34M$8.67M
2016-03-31$13.93M$3.95M$9.98M401.12%
2015-12-31$3.29M$5.31M-$2.02M-26.87%
2015-03-31$1.34M$3.78M-$2.44M
2014-12-31$12.32M$9.38M$2.94M
2014-03-31-$5.84M$4.03M-$9.87M
2013-12-31$8.51M$3.75M$4.77M260.58%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$156.12M$34.88M$121.23M123.59%
2024-12-31$213.39M$41.04M$172.35M108.04%
2023-12-31$183.5M$38.17M$145.34M105.67%
2022-12-31$89.18M$24.03M$65.15M71.29%
2021-12-31$97.99M$27.46M$70.54M113.56%
2020-12-31$57.27M$33.86M$23.41M1668.64%
2019-12-31$41.76M$41.56M$207,000.000.42%
2018-12-31$38.19M$46.81M-$8.62M
2017-12-31$39.21M$35.1M$4.11M112.70%
2016-12-31$38.56M$21.38M$17.18M174.93%
2015-12-31$10.68M$16M-$5.32M
2014-12-31$21.05M$20.5M$553,000.00
2013-12-31$31.04M$17.64M$13.4M112.97%
2012-12-31-$1.65M$23.13M-$24.78M-136.97%